MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by AARBAKKE, J.
Right arrow Articles by UELAND, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by AARBAKKE, J.
Right arrow Articles by UELAND, P. M.

Molecular Pharmacology, Vol 19, 463-469, Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics

Interaction of S-Adenosylhomocysteine with Isolated Rat Hepatocytes

JARLE AARBAKKE 1 and PER M. UELAND 1

1 Department of Pharmacology, University of Bergen School of Medicine, Bergen, Norway

The time course of the association of radioactivity with isolated hepatocytes incubated in the presence of S-[14C]adenosylhomocysteine was characterized by an initial burst phase lasting for less than 15 sec (Phase I) followed by a slow linear phase (Phase II). Phase I was due to association of S-[14C]adenosylhomocysteine with the hepatocytes. The possibiity of intracellular resynthesis of S-[14C]adenosylhomocysteine from [14C]adenosine was ruled out. The process showed slight temperature dependence, and there was no effect of 2,4-dinitrophenol. These data argue against the possibility that Phase I was related to active uptake of S-[14C]adenosylhomocysteine, but rather suggest binding of this compound to an acceptor on the cell surface. Competition studies showed that S-adenosylhomocysteine was the preferred ligand of this acceptor. Phase II corresponded to intracellular accumulation of 14C-labeled adenine nucleotides and was nearly completely abolished by inhibitors of enzymatic hydrolysis of S-adenosylhomocysteine, such as adenosine and homocysteine. This process was explained by extracellular hydrolysis of S-[14C]adenosylhomocysteine catalyzed by S-adenosylhomocysteine hydrolase leaking out of the cells, followed by rapid uptake of [14C]adenosine. Trapping of adenosine formed from S-adenosylhomocysteine directed the extracellular enzyme catalysis towards hydrolysis. Extracellular hydrolysis of S-adenosylhomocysteine was the rate-limiting step in this sequence of events. It is concluded that S-adenosylhomocysteine was not taken up by rat hepatocytes as an intact molecule.

Note:
ACKNOWLEDGMENTS The authors wish to thank Hallvard Bergesen and Audun Høylandskær for excellent technical assistance.

Submitted on July 14, 1980
Accepted on December 8, 1980







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics